Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (EUR)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Products

          

Biopharma

- - 41.21B 43.95B 46.23B

CAPEX

- - -2.91B -3.2B -1.76B

Operating Income

- - 11.25B 11.28B 12.12B

Consumer Healthcare

4.52B 5.14B 5.23B - -

CAPEX

-79M -98M -118M - -

Gross Profit

- - - - -

Operating Income

1.49B 1.81B 1.44B - -

Pharmaceuticals Excl. Consumer Healthcare

27.23B 31.34B - - -

CAPEX

-1.47B -1.49B - - -

Gross Profit

- - - - -

Operating Income

9.41B 11.04B - - -

Vaccines

7.42B 8.9B - - -

CAPEX

-490M -615M - - -

Gross Profit

- - - - -

Operating Income

2.61B 3.17B - - -

Pharmaceuticals

- - - - -

CAPEX

- - - - -

Gross Profit

- - - - -

Operating Income

- - - - -

Veterinary Drugs

          

Others

- 7M - 339M 487M

Operating Income

-2.8B -2.98B -15M 58M 26M

Operating Income

- - - - -

Operating Income

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (EUR)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States

14.38B 18.28B 18.51B 19.99B 22.18B

Total Assets

2.23B 2.46B 2.32B 21.12B 22.92B

Rest of The World

7.85B 8.39B 13.46B 12.07B 9.66B

Total Assets

2.23B 2.42B 2.09B 2.74B 2.41B

Europe (Excluding France)

- - 8.01B 7.21B 7.46B

Total Assets

9.76B 8.75B 8.14B 5.74B 7.73B

China

2.72B 3.12B - - 2.62B

Total Assets

- - - - 122M

France

- - 2.38B 1.81B 1.71B

Total Assets

3.25B 2.88B 3.08B 3.11B 3.12B

Europe (Excl. Russia)

9.76B 10B - - -

Russia

575M 674M - - -

Brazil

815M 927M - - -

South Korea

- - - - -

Asia (Excl. South Asia)

- - - - -

Total Assets

48.06B 49.89B 49.4B 43.38B -

Africa, Middle East and South Asia

- - - - -

Eurasia

- - - - -

Africa, Middle East

- - - - -

Asia

- - - - -

Other Emerging Markets

- - - - -

North America (Excluding United States)

- - 704M - -

Total Assets

13.95B 15B 18.85B - -

Latin America

- - - - -

Japan

1.66B 1.61B - - -

Europe

- - - - -